Author Index: I
• ESTIMATING THE COST-EFFECTIVENESS OF USING CIRCULATING TUMOR CELL DETECTION TO GUIDE SYSTEMIC THERAPY IN STAGE IA PRIMARY BREAST CANCER
• THE USE OF BEST-WORST SCALING CASE 2 TO ESTIMATE INDIVIDUALIZED PREFERENCES FOR VALUE CLARIFICATION AND DECISION SUPPORT
• THE COST-EFFECTIVENESS OF POINT-OF-CARE TROPONIN TESTING TO DIAGNOSE ACUTE CORONARY SYNDROME IN PRIMARY CARE
• THE USE OF BEST-WORST SCALING CASE 2 TO ESTIMATE INDIVIDUALIZED PREFERENCES FOR VALUE CLARIFICATION AND DECISION SUPPORT
• THE COST-EFFECTIVENESS OF POINT-OF-CARE TROPONIN TESTING TO DIAGNOSE ACUTE CORONARY SYNDROME IN PRIMARY CARE